PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model
Current therapies for Alzheimer’s disease (AD) are symptomatic and do not target the underlying Aβ pathology and other important hallmarks including neuronal loss. PPARγ-coactivator-1α (PGC-1α) is a cofactor for transcription factors including the peroxisome proliferator-activated receptor-γ (PPARγ)...
Main Authors: | Katsouri, L, Lim, Y, Blondrath, K, Eleftheriadou, I, Lombardero, L, Birch, A, Mirzaei, N, Irvine, E, Mazarakis, N, Sastre, M |
---|---|
Format: | Journal article |
Published: |
National Academy of Sciences
2016
|
Similar Items
-
PPARγ co-activator-1α (PGC-1α) reduces amyloid-β generation through a PPARγ-dependent mechanism
by: Katsouri, L, et al.
Published: (2011) -
α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.
by: Hazel L Roberts, et al.
Published: (2017-01-01) -
Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration
by: Katsouri, L, et al.
Published: (2012) -
α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP
by: Roberts, HL, et al.
Published: (2017) -
Conformational Changes and Unfolding of β-Amyloid Substrates in the Active Site of γ-Secretase
by: Jakub Jakowiecki, et al.
Published: (2024-02-01)